Literature DB >> 16009909

Ethnic differences in acetylcholinesterase inhibitor use for Alzheimer disease.

Kala M Mehta1, Maggie Yin, Cynthia Resendez, Kristine Yaffe.   

Abstract

Acetylcholinesterase inhibitors (AChIs) have been demonstrated to improve Alzheimer disease symptoms. Whether the use of AChIs varies by ethnicity is unknown. More than 2500 ethnically diverse patients (6% African American, 14% Latino, and 7% Asian patients) from the Alzheimer's Disease Research Centers in California were studied. Compared with white patients with AD, minority patients had 40% lower odds of AChI use (odds ratio 0.6, 95% confidence interval: 0.5 to 0.7).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16009909      PMCID: PMC2830864          DOI: 10.1212/01.wnl.0000167545.38161.48

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R S Doody; J C Stevens; C Beck; R M Dubinsky; J A Kaye; L Gwyther; R C Mohs; L J Thal; P J Whitehouse; S T DeKosky; J L Cummings
Journal:  Neurology       Date:  2001-05-08       Impact factor: 9.910

2.  Black and white differences in cognitive function test scores: what explains the difference?

Authors:  Kala M Mehta; Eleanor M Simonsick; Ronica Rooks; Anne B Newman; Sandra K Pope; Susan M Rubin; Kristine Yaffe
Journal:  J Am Geriatr Soc       Date:  2004-12       Impact factor: 5.562

3.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

4.  Ethnic differences in the prevalence and pattern of dementia-related behaviors.

Authors:  Kaycee M Sink; Kenneth E Covinsky; Robert Newcomer; Kristine Yaffe
Journal:  J Am Geriatr Soc       Date:  2004-08       Impact factor: 5.562

5.  Prevalence of dementia in three ethnic groups: the South Florida program on aging and health.

Authors:  Jasenka Demirovic; Ronald Prineas; David Loewenstein; Judy Bean; Ranjan Duara; Steven Sevush; Jose Szapocznik
Journal:  Ann Epidemiol       Date:  2003-07       Impact factor: 3.797

Review 6.  Research priorities in the evolving demographic landscape of Alzheimer disease and associated dementias.

Authors:  Ramón Valle; Brason Lee
Journal:  Alzheimer Dis Assoc Disord       Date:  2002       Impact factor: 2.703

7.  Racial and ethnic disparities in prescription coverage and medication use.

Authors:  Becky Briesacher; Rhona Limcangco; Darrell Gaskin
Journal:  Health Care Financ Rev       Date:  2003
  7 in total
  32 in total

1.  Clinic visits and prescribing patterns among Veterans Affairs Maryland Health Care System dementia patients.

Authors:  G B Rattinger; C D Mullins; I H Zuckerman; E Onukwugha; S Delisle
Journal:  J Nutr Health Aging       Date:  2010-10       Impact factor: 4.075

2.  Pharmacological treatment of Alzheimer's disease: effect of race and demographic variables.

Authors:  Santiago Hernandez; McKee J McClendon; Xiao-Hua Andrew Zhou; Michael Sachs; Alan J Lerner
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression.

Authors:  Michelle M Mielke; Jeannie-Marie Leoutsakos; Chris D Corcoran; Robert C Green; Maria C Norton; Kathleen A Welsh-Bohmer; JoAnn T Tschanz; Constantine G Lyketsos
Journal:  Alzheimers Dement       Date:  2012-02-01       Impact factor: 21.566

4.  Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.

Authors:  Ganesh M Babulal; Yakeel T Quiroz; Benedict C Albensi; Eider Arenaza-Urquijo; Arlene J Astell; Claudio Babiloni; Alex Bahar-Fuchs; Joanne Bell; Gene L Bowman; Adam M Brickman; Gaël Chételat; Carrie Ciro; Ann D Cohen; Peggye Dilworth-Anderson; Hiroko H Dodge; Simone Dreux; Steven Edland; Anna Esbensen; Lisbeth Evered; Michael Ewers; Keith N Fargo; Juan Fortea; Hector Gonzalez; Deborah R Gustafson; Elizabeth Head; James A Hendrix; Scott M Hofer; Leigh A Johnson; Roos Jutten; Kerry Kilborn; Krista L Lanctôt; Jennifer J Manly; Ralph N Martins; Michelle M Mielke; Martha Clare Morris; Melissa E Murray; Esther S Oh; Mario A Parra; Robert A Rissman; Catherine M Roe; Octavio A Santos; Nikolaos Scarmeas; Lon S Schneider; Nicole Schupf; Sietske Sikkes; Heather M Snyder; Hamid R Sohrabi; Yaakov Stern; Andre Strydom; Yi Tang; Graciela Muniz Terrera; Charlotte Teunissen; Debora Melo van Lent; Michael Weinborn; Linda Wesselman; Donna M Wilcock; Henrik Zetterberg; Sid E O'Bryant
Journal:  Alzheimers Dement       Date:  2018-12-13       Impact factor: 21.566

5.  Telepsychiatry for Neurocognitive Testing in Older Rural Latino Adults.

Authors:  Ipsit V Vahia; Bernardo Ng; Alvaro Camacho; Veronica Cardenas; Mariana Cherner; Colin A Depp; Barton W Palmer; Dilip V Jeste; Zia Agha
Journal:  Am J Geriatr Psychiatry       Date:  2014-08-20       Impact factor: 4.105

6.  Race and cognitive decline among community-dwelling elders with mild cognitive impairment: findings from the Memory and Medical Care Study.

Authors:  Hochang B Lee; Amanda K Richardson; Betty S Black; Andrew D Shore; Judith D Kasper; Peter V Rabins
Journal:  Aging Ment Health       Date:  2011-10-14       Impact factor: 3.658

Review 7.  Facilitating Alzheimer disease research recruitment.

Authors:  Joshua D Grill; James E Galvin
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Jan-Mar       Impact factor: 2.703

8.  Racial and ethnic disparities in the treatment of dementia among Medicare beneficiaries.

Authors:  Ilene H Zuckerman; Priscilla T Ryder; Linda Simoni-Wastila; Thomas Shaffer; Masayo Sato; Lirong Zhao; Bruce Stuart
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2008-09       Impact factor: 4.077

9.  Memantine and acetylcholinesterase inhibitor treatment in cases of CDR 0.5 or questionable impairment.

Authors:  McKee J McClendon; Santiago Hernandez; Kathleen A Smyth; Alan J Lerner
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

10.  Ethnoracial Differences in Lewy Body Diseases with Cognitive Impairment.

Authors:  Andrea M Kurasz; Glenn E Smith; Maria G McFarland; Melissa J Armstrong
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.